ArticleAmerican journal of translational research2016

COUP-TFII promotes colorectal carcinoma resistance to doxorubicin involving inhibition of epithelial-mesenchymal transition [corrected].

Xiang Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.